TLR4 expression is similar both at the MDS step and after progression to AML, but despite these similarities the functional impact of TLR4 seems to differ between steps with a proapoptotic effect only in the preleukemic malignant cells. This evidence concerns the gene TLR4 and acute myeloid leukemia.